NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.

Marcus V. B. Malachias,Pardeep S. Jhund,Brian Claggett,Magnus O. Wijkman,Rhonda Bentley-Lewis,Nishi Chaturvedi,Akshay S. Desai,Steven M. Haffner,Hans Henrik Parving,Margaret F. Prescott,Scott D. Solomon,Dick de Zeeuw,John J.V. McMurray,Marc A. Pfeffer

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.

2020

Marcus V. B. Malachias
Pardeep S. Jhund
Brian Claggett
Magnus O. Wijkman
Rhonda Bentley-Lewis
Nishi Chaturvedi
Akshay S. Desai
Steven M. Haffner
Hans Henrik Parving
Margaret F. Prescott
Scott D. Solomon
Dick de Zeeuw
John J.V. McMurray
Marc A. Pfeffer

Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) improves the discriminatory ability of risk‐prediction models in type 2 diabetes mellitus (T2DM) but is not yet used in clinical pra...

Keywords:

Diabetes mellitus
Cardiology
Type 2 Diabetes Mellitus
Proportional hazards model
Natriuretic peptide
Medicine
Internal medicine
high risk patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations